Navigation Links
Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
Date:9/17/2008

desire to ensure that the study is appropriately powered to generate a data set that, if the results are positive, will establish a path forward for a pivotal trial," stated Vaughn M. Kailian, President and Chief Executive Officer of Memory Pharmaceuticals. "Enrollment in the CIAS trial has gone well, and we expect the expansion of the trial to continue on that trend. Most importantly, this announcement, coupled with the plan to commence a further trial in Alzheimer's disease later this year, underscores the collective excitement of Roche and Memory about the potential of R3487/MEM 3454 in both of these debilitating diseases."

The Phase 2 trial is in patients with stable schizophrenia who are receiving atypical antipsychotic therapy. Subjects in the study are randomized to receive 5 mg, 15 mg or 50 mg of R3487/MEM 3454 or placebo once daily for a period of eight weeks. The primary objective of the trial is to assess the effectiveness of R3487/MEM 3454 in CIAS using the MATRICS Consensus Cognitive Battery (MCCB). Secondary objectives include measures of other symptoms of schizophrenia and functional capacity.

About R3487/MEM 3454

R3487/MEM 3454 is a partial agonist of the nicotinic alpha-7 receptor, a highly specialized receptor found in the central nervous system. In a recently completed Phase 2a study in Alzheimer's disease patients, R3487/MEM 3454 demonstrated a statistically significant effect on multiple measures of cognition. In May 2008, Roche exercised its option to license R3487/MEM 3454 for future development and commercialization.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at '/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
2. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
3. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
4. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
5. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
6. How Big Is Your Brain? Its Size May Protect You from Memory Loss
7. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
8. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
9. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
10. Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease
11. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Taskforce representing Canada,s living victims of ... the Minister and Health Canada have put into this program ... of the thalidomide survivors, and more than 70% of them ... annual adjustments for inflation. Certain of the thalidomide ... on the severity of their disability, tax free, with inflation ...
(Date:5/22/2015)... BOTHELL, Wash. , May 22, 2015  BioLife Solutions, ... marketer of proprietary clinical grade hypothermic storage and ... products for cells and tissues ("BioLife" or the "Company"), ... 2015 Marcum MicroCap Conference. The Company is ... on Wednesday, May 27, 2015 at the Grand Hyatt Hotel ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... India, Oct. 10, 2011 Groupe Athena, Inc. (Pink sheets ... quarter ending September 30, 2011 which generated pretax earnings of ... for the same period. With the most recent strong quarter, ... share. The record quarterly revenue was significant in that it ...
... HILLS, N.J., Oct. 10, 2011 The New Jersey Patient ... in the Garden State, encourages men and their families to ... U.S. Preventive Services Task Force (USPSTF) recommended healthy men should ... of routine cancer screening. This decision was ...
Cached Medicine Technology:Groupe Athena, Inc. Reports Record First Quarter Revenues 2Groupe Athena, Inc. Reports Record First Quarter Revenues 3NJ Docs Say Cancer Detection Tool Saves Lives 2
(Date:5/26/2015)... DC (PRWEB) May 26, 2015 ... podiatrist Dr. Enzo J. Leone (Pasadena and ... service as the Maryland Podiatric Medical Association (MPMA) President ... , Dr. Leone received his Doctorate in Podiatric Medicine ... at the West Jersey Hospital in Voorhees, New Jersey. ...
(Date:5/26/2015)... May 26, 2015 Pacifica ... during the Memorial Day weekend, celebrating the outstanding ... on Pacifica’s picturesque Ladera Lane campus, located in ... and alumni traveled to Santa Barbara from all ... , The 2015 commencement ceremonies featured ...
(Date:5/26/2015)... Hanover, MA (PRWEB) May 26, 2015 ... the much acclaimed Boston Pops and their renowned Conductor ... wonderful event on Wednesday evening, June 10, 2015—the ... . , The Boston Pops Night is set to ... guest, Boston Pops Conductor Keith Lockhart who tragically lost ...
(Date:5/26/2015)... The professionals from Marietta Vet Clinic ... helping local rescue pets with a parking lot cookout ... Kimmerling DDS, Suzanna Aguilera DMD and Garrick McGrath DMD ... 100% of proceeds from the extravaganza. , Tents, grills ... to help save unwanted, local animals. Doctors and ...
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 Carl ... at Pinehurst Surgical Center in Pinehurst, N.C. have launched ... sinus surgery patients about chronic sinusitis and the benefits ... that can be used to determine if someone is ... questions about symptoms and other factors that can contribute ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2
... French . The medicinal use of cannabis has ... large for many years as an alternative to standard pharmaceutical ... may have unwanted side effects. A new study by McGill ... that cannabis may offer relief to patients suffering from chronic ...
... cannabis reduces pain, improves mood and helps sleep, ... Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091414.pdf ... pain due to damage or dysfunction of the ... include opioids, anticonvulsants, antidepressants and local anesthetics, but ...
... Amanda Gardner HealthDay Reporter , FRIDAY, Aug. 27 ... real and pervasive condition, new research suggests there is a ... either to get drugs or gain special privileges in school. ... to do a good job of faking on a number ...
... . , Montreal, August 27, 2010 While some ... scientists at the University of Toronto and the University of ... in some adolescents. Published in the journal Addictive Behaviors ... in Teens (NDIT) study based at the University of Montreal ...
... HealthDay Reporter , THURSDAY, Aug. 26 (HealthDay News) ... salmonella bacteria in feed given to chickens at the two ... finding, at Iowa-based Wright County Egg and Hillandale Farms, ... of the salmonella outbreak, government experts said at a press ...
... Traumatic brain injury, currently considered a singular event by ... instead the beginning of an ongoing process that impacts ... diseases and disorders that can reduce life expectancy, according ... at Galveston. As such, traumatic brain injury should ...
Cached Medicine News:Health News:Research demonstrates benefits of medical cannabis as a treatment for chronic pain 2Health News:Smoked cannabis reduces chronic pain 2Health News:Some Fake ADHD to Get Meds, Special Treatment 2Health News:Some Fake ADHD to Get Meds, Special Treatment 3Health News:Smoking increases depressive symptoms in teens 2Health News:Chicken Feed May Be Source of Salmonella in Egg Recall: FDA 2Health News:Chicken Feed May Be Source of Salmonella in Egg Recall: FDA 3Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 2Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 3Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 4
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
... The BcMag Streptavidin magnetic beads ... capture of biotinylated molecules such ... protein from cell lysates or ... its highly dispersed, it can ...
... beads are 1 m ... to a form of ... be useful as ligands ... mRNA isolation and the ...
Medicine Products: